• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

血管性血友病因子作为移植相关性血栓性微血管病的预测因子。

von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.

机构信息

Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, People's Republic of China.

Information and Statistics Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, People's Republic of China.

出版信息

Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029619892684. doi: 10.1177/1076029619892684.

DOI:10.1177/1076029619892684
PMID:32088973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256332/
Abstract

von Willebrand factor is a useful predictor and prognostic measure for TA-TMA, which may help clinicians identify and manage this life-threatening disease earlier.

摘要

血管性血友病因子是 TA-TMA 的一个有用的预测指标和预后指标，这可能有助于临床医生更早地识别和治疗这种危及生命的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74c/7256332/d99a0b3381ca/10.1177_1076029619892684-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74c/7256332/4ecc13497fae/10.1177_1076029619892684-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74c/7256332/d99a0b3381ca/10.1177_1076029619892684-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74c/7256332/4ecc13497fae/10.1177_1076029619892684-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74c/7256332/d99a0b3381ca/10.1177_1076029619892684-fig2.jpg

相似文献

1
von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.血管性血友病因子作为移植相关性血栓性微血管病的预测因子。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029619892684. doi: 10.1177/1076029619892684.
2
Influenza-associated thrombotic microangiopathy with unbalanced von Willebrand factor and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 levels in a heterozygous protein S-deficient boy.一名杂合子蛋白S缺乏男孩患流感相关血栓性微血管病，伴有血管性血友病因子失衡以及含血小板反应蛋白基序的解聚素和金属蛋白酶13水平异常
Pediatr Int. 2016 Sep;58(9):926-9. doi: 10.1111/ped.13014. Epub 2016 Jul 20.
3
ADAMTS13 protease or lack of von Willebrand factor protects irradiation and melanoma-induced thrombotic microangiopathy in zebrafish.ADAMTS13 蛋白酶或缺乏血管性血友病因子可保护斑马鱼的辐射和黑色素瘤诱导的血栓性微血管病。
J Thromb Haemost. 2022 Oct;20(10):2270-2283. doi: 10.1111/jth.15820. Epub 2022 Aug 7.
4
H1N1 influenza (swine flu)-associated thrombotic microangiopathy with a markedly high plasma ratio of von Willebrand factor to ADAMTS13.甲型H1N1流感（猪流感）相关的血栓性微血管病，血管性血友病因子与含血小板解聚蛋白及金属蛋白酶13的血浆比率显著升高。
Intern Med. 2011;50(6):643-7. doi: 10.2169/internalmedicine.50.4620. Epub 2011 Mar 15.
5
Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections.骨髓活检标本中证实的晚期移植相关性血栓性微血管病与慢性移植物抗宿主病和病毒感染有关。
Eur J Haematol. 2024 May;112(5):819-831. doi: 10.1111/ejh.14174. Epub 2024 Jan 20.
6
Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.肝移植术后患者 ADAMTS13 和血管性血友病因子水平的变化。
Thromb Res. 2013 Mar;131(3):225-9. doi: 10.1016/j.thromres.2012.12.002. Epub 2012 Dec 23.
7
Decreased ADAMTS13 levels in patients after living donor liver transplantation.肝移植术后患者 ADAMTS13 水平降低。
Thromb Res. 2009 Nov;124(5):541-5. doi: 10.1016/j.thromres.2009.03.010. Epub 2009 May 6.
8
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.纤维蛋白溶酶对血管性血友病因子的裂解作用可作为血栓性微血管病中 ADAMTS13 缺乏症的紧急旁路。
Circulation. 2014 Mar 25;129(12):1320-31. doi: 10.1161/CIRCULATIONAHA.113.006727. Epub 2014 Jan 21.
9
Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy.患者血栓性微血管病中可溶性血小板糖蛋白 VI (GPVI) 血浆水平升高。
Thromb Res. 2014 Mar;133(3):440-4. doi: 10.1016/j.thromres.2013.11.023. Epub 2013 Dec 1.
10
The role of ADAMTS-13 in the coagulopathy of sepsis.ADAMTS-13 在脓毒症凝血障碍中的作用。
J Thromb Haemost. 2018 Apr;16(4):646-651. doi: 10.1111/jth.13953. Epub 2018 Feb 2.

引用本文的文献

1
Translating biomarker insights into practice: a path forward in TA-TMA management.将生物标志物见解转化为实践：TA-TMA 管理的前进之路。
Front Med (Lausanne). 2025 May 8;12:1550365. doi: 10.3389/fmed.2025.1550365. eCollection 2025.
2
Transplant-associated TMA: the conundrum of diagnosis and treatment.移植相关血栓性微血管病：诊断与治疗的难题
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):206-213. doi: 10.1182/hematology.2024000545.
3
Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy.

本文引用的文献

1
VWF (von Willebrand Factor) Comes in From the Cold As a Strategy to Improve Platelet Storage.血管性血友病因子（VWF）“走出冷宫”成为改善血小板储存的一种策略。
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1893-1895. doi: 10.1161/ATVBAHA.119.313069. Epub 2019 Sep 25.
2
Extracellular RNA released due to shear stress controls natural bypass growth by mediating mechanotransduction in mice.由于切应力释放的细胞外 RNA 通过介导小鼠中的机械转导控制自然旁路生长。
Blood. 2019 Oct 24;134(17):1469-1479. doi: 10.1182/blood.2019001392.
3
Shear stress and platelet-induced tensile forces regulate ADAMTS13-localization within the platelet thrombus.
ADAMTS13对血管性血友病因子多聚体的过度裂解可能预示着移植相关血栓性微血管病的进展。
Res Pract Thromb Haemost. 2024 Jul 22;8(5):102517. doi: 10.1016/j.rpth.2024.102517. eCollection 2024 Jul.
4
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis.纤溶酶切割的血管性血友病因子作为微血管血栓形成的生物标志物。
Blood. 2024 May 16;143(20):2089-2098. doi: 10.1182/blood.2023021265.
5
Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation.高迁移率族蛋白 B1 和血小板微粒在造血干细胞移植患者中的相关性研究。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231193398. doi: 10.1177/10760296231193398.
6
A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy.移植相关性血栓性微血管病的诊断、预后和风险的血液和尿液生物标志物的系统评价。
Front Immunol. 2023 Feb 2;13:1064203. doi: 10.3389/fimmu.2022.1064203. eCollection 2022.
7
Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation.异基因干细胞移植后的内皮功能障碍综合征
Cancers (Basel). 2023 Jan 22;15(3):680. doi: 10.3390/cancers15030680.
8
Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.与造血干细胞移植相关的血栓性微血管病相关的体征和症状的系统评价。
Transplant Cell Ther. 2023 Apr;29(4):282.e1-282.e9. doi: 10.1016/j.jtct.2022.12.023. Epub 2022 Dec 31.
9
Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease.血管性血友病因子、因子 VIII 和其他急性期反应物作为慢性移植物抗宿主病中炎症和内皮功能障碍的生物标志物。
Front Immunol. 2021 Apr 30;12:676756. doi: 10.3389/fimmu.2021.676756. eCollection 2021.
剪切应力和血小板诱导的拉伸力调节ADAMTS13在血小板血栓中的定位。
Res Pract Thromb Haemost. 2019 Mar 23;3(2):254-260. doi: 10.1002/rth2.12196. eCollection 2019 Apr.
4
Early myeloid-derived suppressor cells (HLA-DR/CD33CD16) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT.早期髓系来源的抑制细胞（HLA-DR/CD33CD16）经粒细胞集落刺激因子扩增可预防人源化小鼠的急性移植物抗宿主病（GVHD），并可能降低 allo-HSCT 后患者的 GVHD 发生率。
J Hematol Oncol. 2019 Mar 18;12(1):31. doi: 10.1186/s13045-019-0710-0.
5
Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Study.阵发性睡眠性血红蛋白尿症患者异基因造血干细胞移植的良好结局：一项单中心研究。
Biol Blood Marrow Transplant. 2019 Aug;25(8):1544-1549. doi: 10.1016/j.bbmt.2019.02.024. Epub 2019 Mar 8.
6
The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis.ADAMTS13 检测在血栓性微血管病和血栓形成中的诊断和管理中的作用。
Blood. 2018 Aug 30;132(9):903-910. doi: 10.1182/blood-2018-02-791533. Epub 2018 Jul 13.
7
Inflammation, von Willebrand factor, and ADAMTS13.炎症、血管性血友病因子和 ADAMTS13。
Blood. 2018 Jul 12;132(2):141-147. doi: 10.1182/blood-2018-02-769000. Epub 2018 Jun 4.
8
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.针对急性白血病患者，在接受 HLA 匹配的同胞或无关供体移植时，使用移植后环磷酰胺预防移植物抗宿主病：代表 ALWP-EBMT。
J Hematol Oncol. 2018 Mar 15;11(1):40. doi: 10.1186/s13045-018-0586-4.
9
Autoregulation of von Willebrand factor function by a disulfide bond switch.通过二硫键开关对血管性血友病因子功能的自动调节
Sci Adv. 2018 Feb 28;4(2):eaaq1477. doi: 10.1126/sciadv.aaq1477. eCollection 2018 Feb.
10
The role of von Willebrand factor in thrombotic microangiopathy.血管性血友病因子在血栓性微血管病中的作用。
Pediatr Nephrol. 2018 Aug;33(8):1297-1307. doi: 10.1007/s00467-017-3744-y. Epub 2017 Jul 26.